Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Predictive Factors for Good Outcome and Mortality After Stent-Retriever Thrombectomy in Patients With Acute Anterior Circulation Stroke.

Yoon W, Kim SK, Park MS, Baek BH, Lee YY.

J Stroke. 2017 Jan;19(1):97-103. doi: 10.5853/jos.2016.00675. Epub 2017 Jan 31.

2.
3.

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group..

Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.

4.

Locally Deliver the Tissue-Type Plasminogen Activator (tPA) Plasmid for Preventing Thrombosis.

Wei KC.

Acta Cardiol Sin. 2015 Mar;31(2):151. No abstract available.

5.

Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy - Case Report and Review of Literature.

Aleksic-Shihabi A, Jadrijevic E, Milekic N, Bulicic AR, Titlic M, Suljic E.

Med Arch. 2016 Feb;70(1):69-71. doi: 10.5455/medarh.2016.70.69-71. Epub 2016 Jan 31.

6.

A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia.

Suzuki Y, Nagai N, Umemura K.

Front Cell Neurosci. 2016 Jan 25;10:2. doi: 10.3389/fncel.2016.00002. eCollection 2016. Review.

7.

The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT.

Zonneveld TP, Algra A, Dippel DW, Kappelle LJ, van Oostenbrugge RJ, Roos YB, Wermer MJ, van der Worp HB, Nederkoorn PJ, Kruyt ND; TRUTH investigators..

BMC Neurol. 2015 Nov 23;15:241. doi: 10.1186/s12883-015-0493-z.

8.

Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke.

Choi JC, Lee JS, Park TH, Park SS, Cho YJ, Park JM, Kang K, Lee KB, Lee SJ, Ko Y, Kim JG, Lee J, Cho KH, Kim JT, Yu KH, Lee BC, Oh MS, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Kim BJ, Bae HJ, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee J, Hong KS.

J Stroke. 2015 Sep;17(3):327-35. doi: 10.5853/jos.2015.17.3.327. Epub 2015 Sep 30.

9.

Development and validation of a simplified Stroke-Thrombolytic Predictive Instrument.

Kent DM, Ruthazer R, Decker C, Jones PG, Saver JL, Bluhmki E, Spertus JA.

Neurology. 2015 Sep 15;85(11):942-9. doi: 10.1212/WNL.0000000000001925. Epub 2015 Aug 19.

10.

Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset.

Cheng NT, Kim AS.

Neurohospitalist. 2015 Jul;5(3):101-9. doi: 10.1177/1941874415583116. Review.

11.

Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke.

Wang HR, Chen M, Wang FL, Dai LH, Fei AH, Liu JF, Li HJ, Shen S, Liu M, Pan SM.

Sci Rep. 2015 Jul 24;5:11743. doi: 10.1038/srep11743.

12.

Physiologic imaging in acute stroke: Patient selection.

Morgan CD, Stephens M, Zuckerman SL, Waitara MS, Morone PJ, Dewan MC, Mocco J.

Interv Neuroradiol. 2015 Aug;21(4):499-510. doi: 10.1177/1591019915587227. Epub 2015 Jun 10. Review.

13.

Analysis of Cynandione A's Anti-Ischemic Stroke Effects from Pathways and Protein-Protein Interactome.

Fang H, Yue R, Ga Y, Zhang Y, Shan L, Zhao J.

PLoS One. 2015 May 8;10(5):e0124632. doi: 10.1371/journal.pone.0124632. eCollection 2015.

14.

Imaging-based management of acute ischemic stroke patients: current neuroradiological perspectives.

Na DG, Sohn CH, Kim EY.

Korean J Radiol. 2015 Mar-Apr;16(2):372-90. doi: 10.3348/kjr.2015.16.2.372. Epub 2015 Feb 27. Review.

15.

A case-control study of the effectiveness of tissue plasminogen activator on 6 month patients--reported outcomes and health care utilization.

Lang CE, Bland MD, Cheng N, Corbetta M, Lee JM.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2914-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.049. Epub 2014 Oct 14.

16.

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.

Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group..

Lancet. 2014 Nov 29;384(9958):1929-35. doi: 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5. Review.

17.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, Murray V, Berge E, del Zoppo GJ.

Cochrane Database Syst Rev. 2014 Jul 29;(7):CD000213. doi: 10.1002/14651858.CD000213.pub3. Review.

18.

Imaging of acute stroke prior to treatment: current practice and evolving techniques.

Mair G, Wardlaw JM.

Br J Radiol. 2014 Aug;87(1040):20140216. doi: 10.1259/bjr.20140216. Epub 2014 Jun 17. Review.

19.

Predictors of Outcome following Stroke due to Isolated M2 Occlusions.

Khan M, Goddeau RP Jr, Zhang J, Moonis M, Henninger N.

Cerebrovasc Dis Extra. 2014 Mar 7;4(1):52-60. doi: 10.1159/000360075. eCollection 2014 Jan.

20.

Imaging Oxygen Metabolism In Acute Stroke Using MRI.

An H, Ford AL, Vo KD, Liu Q, Chen Y, Lee JM, Lin W.

Curr Radiol Rep. 2014 Mar 1;2(3):39.

Supplemental Content

Support Center